Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
Public ClinicalTrials.gov record NCT01129648. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Multi-center, Placebo-Controlled, Combination Study to Evaluate the Urate-Lowering Activity, Safety, and Potential Pharmacokinetic Interaction of Oral BCX4208 and Allopurinol Administered in Subjects With Gout
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate safety and efficacy of BCX4208 alone and in combination with allopurinol in subjects with gout.
Study identification
- NCT ID
- NCT01129648
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 69 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Nov 2010 (Actual)
- Completion
- Nov 2010 (Actual)
- Last update posted
- Jan 23, 2012
2010
United States locations
- U.S. sites
- 18
- U.S. states
- 17
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Scottsdale | Arizona | 85251 | — |
| Not listed | Irvine | California | 92618 | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | Honolulu | Hawaii | 96814 | — |
| Not listed | Boise | Idaho | 83704 | — |
| Not listed | Lexington | Kentucky | 40504 | — |
| Not listed | Frederick | Maryland | 21702 | — |
| Not listed | Olive Branch | Mississippi | 38654 | — |
| Not listed | Billings | Montana | 59107 | — |
| Not listed | Omaha | Nebraska | 68134 | — |
| Not listed | Reno | Nevada | 89502 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Charlotte | North Carolina | 28211 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Duncansville | Pennsylvania | 16635 | — |
| Not listed | Rapid City | South Dakota | 57702 | — |
| Not listed | Bristol | Tennessee | 37620 | — |
| Not listed | Dallas | Texas | 75235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01129648, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2012 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01129648 live on ClinicalTrials.gov.